Hughes
DA, Nicholls
K, Shankar
SP,
et al. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J Med Genet. 2017;54(4):288–296. Erratum in: J Med Genet. 2018;55(6):422–429.
[PubMed: 27834756]
; PubMed Central PMCID: PMC5502308.